B-CELL NON-HODGKIN LYMPHOMA (NHL)
Clinical trials for B-CELL NON-HODGKIN LYMPHOMA (NHL) explained in plain language.
Never miss a new study
Get alerted when new B-CELL NON-HODGKIN LYMPHOMA (NHL) trials appear
Sign up with your email to follow new studies for B-CELL NON-HODGKIN LYMPHOMA (NHL), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Last-Resort hope: new drug offered to lymphoma patients with no options left
Disease control AVAILABLEThis program gives people with certain types of lymphoma (like follicular lymphoma or diffuse large B-cell lymphoma) who have tried all other treatments access to an experimental drug called odronextamab. The goal is to provide a possible treatment option when no others are avail…
Matched conditions: B-CELL NON-HODGKIN LYMPHOMA (NHL)
Sponsor: Regeneron Pharmaceuticals • Aim: Disease control
Last updated May 07, 2026 18:39 UTC
-
New cell therapy aims to shrink stubborn lymphomas
Disease control Recruiting nowThis early study tests a new treatment called CT1182 for adults with B-cell non-Hodgkin lymphoma that has come back or not responded to other therapies. About 24 participants will receive the treatment to see if it is safe and can shrink tumors. The goal is to find the best dose …
Matched conditions: B-CELL NON-HODGKIN LYMPHOMA (NHL)
Phase: EARLY_PHASE1 • Sponsor: Union Hospital, Tongji Medical College, Huazhong University of Science and Technology • Aim: Disease control
Last updated May 06, 2026 16:15 UTC